Pari Pandharipande's AJR article JOURNAL CLUB: How Radiation Exposure Histories Influence Physician Imaging Decisions: A Multicenter Radiologist Survey Study was mentioned in the Wall Street Journal regarding radiation exposure
Scott Gazelle was recently one of six MGH radiologists inducted as a fellow in the American College of Radiology (ACR). Only 10% of the College's 34,000 members achieve this distinction.
RSNA Press Release - http://www2.rsna.org/timssnet/media/pressreleases/pr_target.cfm?ID=659
An article from Neurology Today discusses the recent meeting of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) in which the panel voted that the evidence is inadequate to demonstrate that beta amyloid PET imaging improves Alzheimer outcomes.
The article also highlights the findings from a recent white paper completed by ICER evaluating the diagnostic value and clinical benefits of testing for Alzheimer's Disease that Steve presented to MEDCAC. The purpose of the white paper was to help inform future research so that it is possible to evaluate different tests for Alzheimer's disease in a way that will generate “adequate” evidence for not only patients and clinicians, but for insurers as well.
A recent study by ITA investigators led by Amy Knudsen, PhD suggests that it may be reasonable to rescreen for colorectal cancer with methods other than colonoscopy following an initial negative exam. Using a microsimulation model of colorectal cancer, researchers found that rescreening at age 60 with colonoscopy every 10 years, CT colonography (aka “virtual colonoscopy”) every 5 years, or fecal occult blood testing (FOBT) or fecal immunochemical testing (FIT) every year greatly reduced the risk for colorectal cancer compared with no further screening. All rescreening strategies provided roughly the same benefit in terms of life-years gained compared with no further screening. However, rescreening with CT colonography, FOBT, or FIT reduced the risk for complications and cost less than rescreening with colonoscopy. The authors estimate that for every person who switches to FOBT or FIT following a negative initial colonoscopy, $450 to $495 could be saved over his or her lifetime. On a population level, switching could lead to savings of $3 billion.